Tamoxifen
Tamoxifen, the first selective estrogen receptor modulator (SERM), has provided       invaluable laboratory and clinical evidence that such drugs can reduce the risk       of breast cancer and increase bone density.
 @SUBJECT$  @PREDICAT$  @OBJECT$  (SERM), has provided       invaluable laboratory and clinical evidence that such drugs can reduce the risk       of breast cancer and increase bone density.